267 filings
Page 3 of 14
8-K
j93gdcmm0wxfjhp9nyq
23 Mar 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:05pm
8-K
re6cvl9c
13 Mar 23
Entry into a Material Definitive Agreement
7:53am
8-K
1v4sg9bb 63kiioead8o
2 Feb 23
Termination of a Material Definitive Agreement
4:05pm
8-K
nag43yv
5 Jan 23
Entry into a Material Definitive Agreement
5:14pm
8-K
5dv3 liis
9 Dec 22
Departure of Directors or Certain Officers
5:07pm
8-K
9t93ye7j218d21e5flvk
14 Nov 22
NightHawk Biosciences Provides Third Quarter 2022 Business Update
4:23pm
8-K
l517n
16 Sep 22
Departure of Directors or Certain Officers
4:34pm
8-K
pl7479knmkiu55
22 Aug 22
Other Events
7:30am
8-K
bf85d8
10 Aug 22
NightHawk Biosciences Provides Second Quarter 2022 Business Update
4:06pm
8-K/A
fz8 zp2ptc
6 Jun 22
Completion of Acquisition or Disposition of Assets
4:29pm
8-K
6o1jhgyjx61o
16 May 22
NightHawk Biosciences Provides First Quarter 2022 Business Update
4:44pm
8-K
e8wsyxds5htfv6i zn
3 May 22
Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open Today
7:15am
8-K
1lt 88aqu
25 Apr 22
Other Events
8:00am
8-K
x059kcbp44l
20 Apr 22
Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics
8:06am
8-K
siwh5v4
18 Apr 22
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
8:35am
8-K
30f5f bogw
24 Mar 22
Other Events
9:00am
8-K
i50e4a6ka9sum
14 Mar 22
Heat Biologics Provides Year-End 2021 Business Update
8:05am
8-K
opmiqgz2xd0e253di
11 Mar 22
Entry into a Material Definitive Agreement
6:28am
8-K
3jmmx 4tt33dfcxpm7i
2 Mar 22
Other Events
4:05pm
8-K
r2el26fxh519rnpk
3 Feb 22
Other Events
4:05pm